Literature DB >> 19196709

Solution structure of the factor H-binding protein, a survival factor and protective antigen of Neisseria meningitidis.

Francesca Cantini1, Daniele Veggi, Sara Dragonetti, Silvana Savino, Maria Scarselli, Giacomo Romagnoli, Mariagrazia Pizza, Lucia Banci, Rino Rappuoli.   

Abstract

Factor H-binding protein is a 27-kDa lipoprotein of Neisseria meningitidis discovered while screening the bacterial genome for vaccine candidates. In addition to being an important component of a vaccine against meningococcus in late stage of development, the protein is essential for pathogenesis because it allows the bacterium to survive and grow in human blood by binding the human complement factor H. We recently reported the solution structure of the C-terminal domain of factor H-binding protein, which contains the immunodominant epitopes. In the present study, we report the structure of the full-length molecule, determined by nuclear magnetic resonance spectroscopy. The protein is composed of two independent barrels connected by a short link. Mapping the residues recognized by monoclonal antibodies with bactericidal or factor H binding inhibition properties allowed us to predict the sites involved in the function of the protein. The structure therefore provides the basis for designing improved vaccine molecules.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19196709      PMCID: PMC2666550          DOI: 10.1074/jbc.C800214200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.

Authors:  Guillermo Madico; Jo Anne Welsch; Lisa A Lewis; Anne McNaughton; David H Perlman; Catherine E Costello; Jutamas Ngampasutadol; Ulrich Vogel; Dan M Granoff; Sanjay Ram
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

Review 2.  A review of vaccine research and development: meningococcal disease.

Authors:  Marc P Girard; Marie-Pierre Preziosi; Maria-Teresa Aguado; Marie Paule Kieny
Journal:  Vaccine       Date:  2006-03-31       Impact factor: 3.641

Review 3.  Complement evasion by human pathogens.

Authors:  John D Lambris; Daniel Ricklin; Brian V Geisbrecht
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

4.  Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins.

Authors:  Shee-Mei Lok; Victor Kostyuchenko; Grant E Nybakken; Heather A Holdaway; Anthony J Battisti; Soila Sukupolvi-Petty; Dagmar Sedlak; Daved H Fremont; Paul R Chipman; John T Roehrig; Michael S Diamond; Richard J Kuhn; Michael G Rossmann
Journal:  Nat Struct Mol Biol       Date:  2008-02-10       Impact factor: 15.369

5.  Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidis.

Authors:  Maria Scarselli; Francesca Cantini; Laura Santini; Daniele Veggi; Sara Dragonetti; Claudio Donati; Silvana Savino; Marzia M Giuliani; Maurizio Comanducci; Federica Di Marcello; Giacomo Romagnoli; Mariagrazia Pizza; Lucia Banci; Rino Rappuoli
Journal:  J Mol Biol       Date:  2008-12-11       Impact factor: 5.469

6.  Structure of an Fab-protease complex reveals a highly specific non-canonical mechanism of inhibition.

Authors:  Christopher J Farady; Pascal F Egea; Eric L Schneider; Molly R Darragh; Charles S Craik
Journal:  J Mol Biol       Date:  2008-05-11       Impact factor: 5.469

Review 7.  Harmful molecular mechanisms in sepsis.

Authors:  Daniel Rittirsch; Michael A Flierl; Peter A Ward
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

8.  Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein.

Authors:  Peter T Beernink; Jo Anne Welsch; Michal Bar-Lev; Oliver Koeberling; Maurizio Comanducci; Dan M Granoff
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

9.  Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

Authors:  Matthew D Snape; Kirsten P Perrett; Karen J Ford; Tessa M John; David Pace; Ly-Mee Yu; Joanne M Langley; Shelley McNeil; Peter M Dull; Francesca Ceddia; Alessandra Anemona; Scott A Halperin; Simon Dobson; Andrew J Pollard
Journal:  JAMA       Date:  2008-01-09       Impact factor: 56.272

10.  Crystal structure of a ternary complex between human prostate-specific antigen, its substrate acyl intermediate and an activating antibody.

Authors:  Renée Ménez; Sandrine Michel; Bruno H Muller; Marc Bossus; Frédéric Ducancel; Colette Jolivet-Reynaud; Enrico A Stura
Journal:  J Mol Biol       Date:  2007-11-22       Impact factor: 5.469

View more
  32 in total

Review 1.  Lipoproteins of bacterial pathogens.

Authors:  A Kovacs-Simon; R W Titball; S L Michell
Journal:  Infect Immun       Date:  2010-10-25       Impact factor: 3.441

Review 2.  Vaccinology in the genome era.

Authors:  C Daniela Rinaudo; John L Telford; Rino Rappuoli; Kate L Seib
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

3.  Expression of factor H binding protein of meningococcus responds to oxygen limitation through a dedicated FNR-regulated promoter.

Authors:  Francesca Oriente; Vincenzo Scarlato; Isabel Delany
Journal:  J Bacteriol       Date:  2009-11-30       Impact factor: 3.490

Review 4.  Structural vaccinology starts to deliver.

Authors:  Philip R Dormitzer; Guido Grandi; Rino Rappuoli
Journal:  Nat Rev Microbiol       Date:  2012-12       Impact factor: 60.633

5.  Defining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigen.

Authors:  Enrico Malito; Agnese Faleri; Paola Lo Surdo; Daniele Veggi; Giulietta Maruggi; Eva Grassi; Elena Cartocci; Isabella Bertoldi; Alessia Genovese; Laura Santini; Giacomo Romagnoli; Erica Borgogni; Sébastien Brier; Carla Lo Passo; Maria Domina; Flora Castellino; Franco Felici; Stijn van der Veen; Steven Johnson; Susan M Lea; Christoph M Tang; Mariagrazia Pizza; Silvana Savino; Nathalie Norais; Rino Rappuoli; Matthew J Bottomley; Vega Masignani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-08       Impact factor: 11.205

6.  Structure of Neisseria meningitidis lipoprotein GNA1162.

Authors:  Xiangyu Cai; Jing Lu; Zhenhua Wu; Chunting Yang; Honglin Xu; Zhijie Lin; Yuequan Shen
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2013-03-28

7.  Vaccines, reverse vaccinology, and bacterial pathogenesis.

Authors:  Isabel Delany; Rino Rappuoli; Kate L Seib
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

8.  Type VI secretion system sheaths as nanoparticles for antigen display.

Authors:  Elena Del Tordello; Olga Danilchanka; Andrew J McCluskey; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

Review 9.  The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens.

Authors:  Davide Serruto; Matthew J Bottomley; Sanjay Ram; Marzia M Giuliani; Rino Rappuoli
Journal:  Vaccine       Date:  2012-05-30       Impact factor: 3.641

10.  A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups.

Authors:  Peter T Beernink; Carla LoPasso; Antonella Angiolillo; Franco Felici; Dan Granoff
Journal:  Mol Immunol       Date:  2009-03-14       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.